Science Current Events | Science News | Brightsurf.com
 

Anti-HIV drug simulation offers 'realistic' tool to predict drug resistance and viral mutation

September 04, 2012
Computer model should help develop better anti-HIV drug combination therapies

Pooling data from thousands of tests of the antiviral activity of more than 20 commonly used anti-HIV drugs, AIDS experts at Johns Hopkins and Harvard universities have developed what they say is the first accurate computer simulation to explain drug effects. Already, the model clarifies how and why some treatment regimens fail in some patients who lack evidence of drug resistance. Researchers say their model is based on specific drugs, precise doses prescribed, and on "real-world variation" in how well patients follow prescribing instructions.

Johns Hopkins co-senior study investigator and infectious disease specialist Robert Siliciano, M.D., Ph.D., says the mathematical model can also be used to predict how well a patient is likely to do on a specific regimen, based on their prescription adherence. In addition, the model factors in each drug's ability to suppress viral replication and the likelihood that such suppression will spur development of drug-resistant, mutant HIV strains.

"With the help of our simulation, we can now tell with a fair degree of certainty what level of viral suppression is being achieved - how hard it is for the virus to grow and replicate - for a particular drug combination, at a specific dosage and drug concentration in the blood, even when a dose is missed," says Siliciano, a professor at the Johns Hopkins University School of Medicine and a Howard Hughes Medical Institute investigator. This information, he predicts, will remove "a lot of the current trial and error, or guesswork, involved in testing new drug combination therapies."

Siliciano says the study findings, to be reported in the journal Nature Medicine online Sept. 2, should help scientists streamline development and clinical trials of future combination therapies, by ruling out combinations unlikely to work.

One application of the model could be further development of drug combinations that can be contained in a single pill taken once a day. That could lower the chance of resistance, even if adherence is not perfect. Such future drug regimens, he says, will ideally strike a balance between optimizing viral suppression and minimizing risk of drug resistance.

Researchers next plan to expand their modeling beyond blood levels of virus to other parts of the body, such as the brain, where antiretroviral drug concentrations can be different from those measured in the blood. They also plan to expand their analysis to include multiple-drug-resistant strains of HIV.

Besides Siliciano, Johns Hopkins joint medical-doctoral student Alireza Rabi was a co-investigator in this study. Other study investigators included doctoral candidates Daniel Rosenbloom, M.S.; Alison Hill, M.S.; and co-senior study investigator Martin Nowak, Ph.D. - all at Harvard University.

Funding support for this study, which took two years to complete, was provided by the National Institutes of Health, with corresponding grant numbers R01-MH54907, R01-AI081600, R01-GM078986; the Bill and Melinda Gates Foundation; the Cancer Research Institute; the National Science Foundation; the Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada; the John Templeton Foundation; and J. Epstein.

Currently, an estimated 8 million of the more than 34 million people in the world living with HIV are taking antiretroviral therapy to keep their disease in check. An estimated 1,178,000 in the United States are infected, including 23,000 in the state of Maryland.

###

For additional information, go to:

http://www.hopkinsmedicine.org/pharmacology_molecular_sciences/faculty/bios/siliciano.html

http://www.hhmi.org/research/investigators/siliciano_bio.html

http://www.nature.com/nm/index.html

Johns Hopkins Medicine


Related Combination Therapies Current Events and Combination Therapies News Articles


New lead against HIV could finally hobble the virus's edge
Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one.

Nodal alone does not produce anti-cancer effects
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.

Chromosomal rearrangement is the key to progress against aggressive infant leukemia
The St. Jude Children's Research Hospital--Washington University Pediatric Cancer Genome Project reports that a highly aggressive form of leukemia in infants has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene.

Researchers detail reasons for ibrutinib therapy discontinuation in CLL
About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in JAMA Oncology.

Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used.

Drug combinations a good approach for infectious fungus, research shows
Researchers at the University of Toronto have discovered that Candida albicans -- a leading cause of potentially fatal hospital-acquired infections -- rarely develops resistance to combination drug therapy and, when it becomes resistant, it also becomes less dangerous.

Genetically engineered antibody-based molecules show enhanced HIV-fighting abilities
Capitalizing on a new insight into HIV's strategy for evading antibodies--proteins produced by the immune system to identify and wipe out invading objects such as viruses--Caltech researchers have developed antibody-based molecules that are more than 100 times better than our bodies' own defenses at binding to and neutralizing HIV, when tested in vitro.

Dramatic decline in risk for heart attacks among HIV-positive Kaiser Permanente members
Previously reported increased risk of heart attacks among HIV-positive individuals has been largely reversed in recent years for Kaiser Permanente's California patients, according to a study published in the current online issue of Clinical Infectious Diseases.

Malaria combination drug therapy for children
A drug combination of artemisinin-naphthoquine should be considered for the treatment of children with uncomplicated malaria in settings where multiple parasite species cause malaria.

Latest research by NTU discovers reasons for malaria's drug resistance
Scientists from Nanyang Technological University (NTU) have discovered exactly how the malaria parasite is developing resistance towards the most important front-line drugs used to treat the disease.
More Combination Therapies Current Events and Combination Therapies News Articles

Antiepileptic Drugs: Combination Therapy and Interactions

Antiepileptic Drugs: Combination Therapy and Interactions
by Jerzy Majkowski (Editor), Blaise F. D. Bourgeois (Editor), Philip N. Patsalos (Editor), Richard H. Mattson (Editor)


This book reviews the use of antiepileptic drugs focusing on the interactions between these drugs and between antiepileptics and other drugs. These interactions can be beneficial or can cause harm. The aim of this book is to increase awareness of the possible impact of combination pharmacotherapies. Pharmacokinetic and pharmacodynamic interactions are discussed supported by clinical and experimental data. The book consists of five sections covering the general concepts and advantages of combination therapies, the principles of drug interactions, the mechanisms of interactions, drug interactions in specific populations or in patients with co-morbid health conditions, and concludes with a look at the future directions for this field of research. The book will be of interest to all who...

Combination Therapy in Hypertension

Combination Therapy in Hypertension
by Joel M. Neutel (Author)


For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be...

Combination Therapy: Headgear with removable appliance: Combination Therapy

Combination Therapy: Headgear with removable appliance: Combination Therapy
by Sunaina Jodhka (Author), Pooja Ahluwalia Sethi (Author), Harmandeep Singh Bedi (Author)


“Combination Therapy” in orthodontics is essentially the “First Phase Therapy” in the management of skeletal class 2 div1 malocclusion with vertical excess. This book serves as a guide to the use of Headgears with removable appliances for the correction of malocclusion in a young patient influencing growth, eliminating functional disturbances and bringing about a change in tooth position. The various appliance designs, modifications, Construction and Stages of treatment have been delineated to unveil the complexity of this precision based treatment modality.

Hematology - Oncology Therapy

Hematology - Oncology Therapy
by Michael Boyiadzis (Author), James Frame (Author), David R. Kohler (Author), Tito Fojo (Author)


The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens More than 500 treatment regimens Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into three sections: Oncology:
Provides detailed information about the...

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy

Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy
by Nicholas J. Lowe (Editor), Alastair Carruthers (Editor), Jean Carruthers (Editor), Zoe Diana Draelos (Editor), Richard Glogau (Editor), Christopher Griffiths (Editor), Arnold W. Klein (Editor), Gary Lask (Editor)


In recent years the demand for rejuvenating treatments for the face has grown dramatically for both men and women. Alongside that demand, a wide variety of treatments have evolved, and a combination of different treatments can often result in much greater improvement than single-treatment approaches. With contributions from an impressive cast of international experts, Textbook of Facial Rejuvenation details current treatments, recommends approaches, and suggests how they may be tailored towards individual needs and combined for optimum results.

Conn's Current Therapy 2015, 1e

Conn's Current Therapy 2015, 1e
by Edward T. Bope MD (Author), Rick D. Kellerman MD (Author)


Ideal for busy medical practitioners who need quick, reliable answers, Conn's Current Therapy 2015 is an easy-to-use, in-depth guide that focuses solely on the most up-to-date treatment protocols for common complaints, acute disease and chronic illness. Drs. Edward T. Bope and Rick D. Kellerman present the expertise and knowledge of hundreds of skilled international leaders on evidence-based clinical management options. With key diagnostic points and treatment recommendation tables, you'll have quick access to the information you need to make accurate clinical decisions. Find answers quickly so you can dedicate more time to treatment with practical and accurate advice by renowned international experts on diagnosis and management, delivered via a templated, at-a-glance approach. Take it...

Principles and Applications of ozone therapy - a practical guideline for physicians

Principles and Applications of ozone therapy - a practical guideline for physicians
by M.D., HMD, ABAAM, Frank Shallenberger (Author)


The Principles and Applications of Ozone Therapy – A Practical Guideline For Physicians is written by a practicing physician in the United States who has been using ozone therapy to treat patients or over 25 years. The book details how and why Dr. Shallenberger, an emergency room specialist, first became interested in ozone therapy. It then describes how his years of successful experience with it in a wide variety of medical conditions compelled him to discover how and why the therapy works so well. Ozone is a highly reactive form of oxygen. So he theorized that it works by enhancing the utilization of oxygen in the cells. In order to determine if he was on the right track, he developed a system which uses an FDA approved pulmonary gas analyzer to measure oxygen...

Abrams' Clinical Drug Therapy: Rationales for Nursing Practice

Abrams' Clinical Drug Therapy: Rationales for Nursing Practice
by Geralyn Frandsen EdD RN (Author), Sandra Smith Pennington RN PhD (Author)


This popular core nursing pharmacology textbook provides unique coverage of nursing interventions for drug therapy with related rationales. Highly praised for its organized and readable presentation, the text explains the "why" behind each nursing action, and emphasizes how drugs work differently in different patients.  The 10th edition has a new fresh design and approach with an added focus on patient safety integrated into the text.  Included in this package is Lippincott's Photo Atlas of Medication Administration (ISBN 9781451112481) which uses the nursing process format to provide step-by-step nursing skills.

Impact Therapy: The Courage to Counsel

Impact Therapy: The Courage to Counsel
by Ed Jacobs (Author), Christine J. Schimmel (Author)


Impact Therapy is an active approach to individual and group counseling developed by Dr. Ed Jacobs, Dr. Chris Schimmel, and Dr. Danie Beaulieu. This multisensory approach to counseling is a form of brief therapy that emphasizes making counseling sessions clear, concrete and thought provoking. Impact Therapy encourages counselors to combine creative counseling techniques with various counseling theories. This innovative approach to counseling has been very well received by school counselors and therapists from all areas of the mental health field including private practice, mental health and drug and alcohol treatment centers, hospitals, and correctional facilities.

Handbook of Neurologic Music Therapy

Handbook of Neurologic Music Therapy
by Michael H. Thaut (Editor), Volker Hoemberg (Editor)


Neurologic Music Therapy (NMT) is a form of music therapy developed for people suffering from cognitive, sensory, or motor dysfunctions - arising from neurological diseases of the nervous system. People who can benefit from this therapy include sufferers from: stroke, traumatic brain injury, Parkinson's and Huntington's disease, cerebral palsy, Alzheimer's disease, autism, and other neurological diseases affecting cognition, movement, and communication (e.g., MS, Muscular Dystrophy, etc).

The Handbook of Neurologic Music Therapy is a comprehensive landmark text presenting a new and revolutionary model of music in rehabilitation, therapy and medicine that is scientifically validated and clinically tested. Each of the 20 clinical techniques is described in detail with specific...

© 2015 BrightSurf.com